The Strategic Imperative of Proactive Regulatory Operations in Pharmaceutical Submissions
admin The pharmaceutical industry, a crucible of innovation and a beacon of hope for countless patients,...
biotech
Unmasking the Silent Threat: The Growing Reality of Lung Cancer in Never-Smokers
For decades, lung cancer has been inextricably linked with tobacco use, a perception rooted in...
Cancer Research Institute Announces 2026 Scientific Achievement Awards Honoring Groundbreaking Immunologists Eric Vivier and Joseph Sun
New York, NY – The Cancer Research Institute (CRI), a global leader in advancing immunotherapy...
Cancer Research Institute Launches Landmark IGNITE Award to Bridge Critical Funding Gap for Next-Generation Immunotherapy Scientists
In October 2025, the Cancer Research Institute (CRI) made a pivotal announcement, unveiling the IGNITE...
Susumu Tonegawa, Nobel Laureate and Visionary Immunologist, Passes Away at 86
The global scientific community is in mourning following the passing of Susumu Tonegawa, PhD, a...
LifeMine Therapeutics Secures $263 Million to Propel Novel Fungal-Derived Immunosuppressant for Organ Transplantation Towards Advanced Clinical Trials
LifeMine Therapeutics, a pioneering biotechnology firm spearheading innovation in natural product drug discovery under the...
Cancer Research Institute Announces 2026 CLIP and Technology Impact Awards, Fueling Next-Generation Immunotherapy Breakthroughs
The Cancer Research Institute (CRI), a global leader in funding cutting-edge immunotherapy research, has proudly...
‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit
The biopharmaceutical sector witnessed a dynamic period marked by significant clinical advancements, strategic corporate maneuvers,...
Cancer Research Institute Bolsters Immunotherapy Frontier with $2.5 Million Boost for Next-Generation Postdoctoral Fellows
The Cancer Research Institute (CRI) has announced its Fall 2025 and Spring 2026 classes of...
Latigo Biotherapeutics Secures $345.6 Million in Landmark IPO, Poised to Challenge Giants in Non-Opioid Pain Market Amidst Biotech Resurgence
Pain drugmaker Latigo Biotherapeutics successfully completed its initial public offering (IPO) on Thursday, August 7,...
